Clinical trial
Comparison of Immunofluorescence Assay (IFA) and Chemiluminiscence Immunoassay (LIAISON®) for Diagnosis of Early Disseminated Lyme Borreliosis in Children, Younger Than 18 Years
NCT03798704 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Immunofluorescence Assay (IFA) and Chemiluminiscence Immunoassay (LIAISON®) for Diagnosis of Early Disseminated Lyme Borreliosis in Children, Younger Than 18 Years
- Lead sponsor
- University Medical Centre Ljubljana
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 29, 2019
- Completion date
- December 31, 2020
- Enrollment
- 349 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.